|
| 36765430 | Cellular senescence in the response of HR<sup>+</sup> breast cancer to radiotherapy and CDK4/6 inhibitors. | J Transl Med | 2023 |
| 37620372 | Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. | Nat Commun | 2023 |
| 37608258 | Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4Â weeks versus 2Â weeks (SHORTER). | BMC Cancer | 2023 |
| 37541280 | National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. | Lancet Oncol | 2023 |
| 37727740 | CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response. | Oncoimmunology | 2023 |
| 37280366 | Emerging evidence for adapting radiotherapy to immunotherapy. | Nat Rev Clin Oncol | 2023 |
| 37142568 | Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia. | Cell Death Dis | 2023 |
| 37475035 | Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022). | J Transl Med | 2023 |
| 37363104 | Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conference. | Oncoimmunology | 2023 |
| 37199227 | Immunologically relevant effects of radiation therapy on the tumor microenvironment. | Essays Biochem | 2023 |
| 36776309 | MRI-LINAC: A transformative technology in radiation oncology. | Front Oncol | 2023 |
| 34819622 | Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. | Nat Rev Clin Oncol | 2022 |
| 35641320 | Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City. | Am J Surg | 2022 |
| 35366506 | Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy. | Breast | 2022 |
| 35358456 | Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC. | Lancet Oncol | 2022 |
| 36505797 | The initial experience of MRI-guided precision prone breast irradiation with daily adaptive planning in treating early stage breast cancer patients. | Front Oncol | 2022 |
| 36010920 | Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study. | Cancers (Basel) | 2022 |
| 35182206 | Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer. | World J Urol | 2022 |
| 35181748 | Author Correction: Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. | Nat Rev Clin Oncol | 2022 |
| 35064104 | Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program. | NPJ Breast Cancer | 2022 |
| 35022867 | Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer. | Breast Cancer Res Treat | 2022 |
| 30836168 | Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities. | Int J Radiat Oncol Biol Phys | 2021 |
| 33495311 | Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER<sup>+</sup> Breast Cancer. | Clin Cancer Res | 2021 |
| 33827904 | Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? | J Immunother Cancer | 2021 |
| 33758842 | Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva. | bioRxiv | 2021 |
| 33637449 | Liver Metastasis Irradiation Can Restore Immunotherapeutic Responsiveness. | Trends Immunol | 2021 |
| 33502482 | Development of a Model to Estimate the Association Between Delay in Cancer Treatment and Local Tumor Control and Risk of Metastases. | JAMA Netw Open | 2021 |
| 34499052 | Rapid, robust, and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals. | JCI Insight | 2021 |
| 34390501 | Serologic response to mRNA COVID-19 vaccination in lymphoma patients. | Am J Hematol | 2021 |
| 33942954 | Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. | Oncologist | 2021 |
| 34078406 | Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy). | J Transl Med | 2021 |
| 34015311 | Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial. | Lancet Oncol | 2021 |
| 34290243 | 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. | Nat Commun | 2021 |
| 34113723 | Redefining postmastectomy radiation contouring in the era of immediate breast reconstruction: An accurate assessment of local recurrence risk. | Clin Transl Radiat Oncol | 2021 |
| 34136730 | Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva. | Pathog Immun | 2021 |
| 33407605 | Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy). | J Transl Med | 2021 |
| 33476307 | Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. | J Clin Invest | 2021 |
| 33093219 | Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer. | Cancer Immunol Res | 2021 |
| 32341524 | Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy. | Nat Rev Clin Oncol | 2020 |
| 31932469 | PTEN as a Guardian of the Genome: Pathways and Targets. | Cold Spring Harb Perspect Med | 2020 |
| 32101479 | The abscopal effect 67 years later: from a side story to center stage. | Br J Radiol | 2020 |
| 32047024 | CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. | Cancer Immunol Res | 2020 |
| 31796520 | First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies. | Clin Cancer Res | 2020 |
| 32092336 | Radiation Therapy in Gabon: Multi-Institutional Collaboration as a Paradigm for Growth in the African Radiation Oncology Sector. | Int J Radiat Oncol Biol Phys | 2020 |
| 33361231 | Capturing Acquired Wisdom, Enabling Healthful Aging, and Building Multinational Partnerships Through Senior Global Health Mentorship. | Glob Health Sci Pract | 2020 |
| 33150045 | Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade. | Oncoimmunology | 2020 |
| 32747819 | Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. | Nat Immunol | 2020 |
| 32943636 | Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. | Nat Commun | 2020 |
| 32917410 | PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer. | Gynecol Oncol | 2020 |
| 32800803 | Radiation Therapy and the In Situ Vaccination Approach. | Int J Radiat Oncol Biol Phys | 2020 |